Loading...
XJPX
4534
Market cap754mUSD
Dec 05, Last price  
3,305.00JPY
1D
-0.45%
1Q
2.16%
Jan 2017
-18.50%
Name

Mochida Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XJPX:4534 chart
P/E
20.61
P/S
1.11
EPS
160.36
Div Yield, %
2.42%
Shrs. gr., 5y
-1.95%
Rev. gr., 5y
0.65%
Revenues
105.16b
+2.21%
70,640,000,00074,070,000,00074,593,000,00075,167,000,00078,548,000,00079,325,000,00086,196,000,00089,230,000,00093,953,000,00087,261,000,00092,274,000,00097,353,000,000106,749,000,000109,652,000,000101,801,000,000102,995,000,000110,179,000,000103,261,000,000102,885,000,000105,159,000,000
Net income
5.69b
+25.03%
4,988,000,0006,030,000,0008,387,000,0008,754,000,0009,869,000,0005,333,000,0009,076,000,0009,152,000,0009,892,000,0007,544,000,0008,150,000,0008,526,000,0009,023,000,0008,435,000,0004,598,000,0008,587,000,00010,569,000,0006,649,000,0004,547,000,0005,685,000,000
CFO
9.35b
P
8,446,000,0006,951,000,0005,585,000,00010,608,000,00012,217,000,0007,061,000,0008,706,000,00011,909,000,00012,478,000,0005,122,000,00015,211,000,0005,583,000,0003,283,000,00012,565,000,0009,347,000,0009,198,000,0007,459,000,0007,297,000,000-7,480,000,0009,354,000,000
Dividend
Mar 30, 202640 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceuticals, skincare products, and diagnostics solutions in Japan. The company provides cardiovascular, analgesic, gastrointestinal, neurological, anti-infective, antidiabetics, and anticancer products, as well as hormone and biological preparations, and biosimilars; diagnostic reagents, such as reagents for fertility/infertility and other reagents; and face and body care, hair care, and skincare products, as well as dermatology, psychiatry, obstetrics, and gynecology products. It also developing drugs for the treatment of intractable diseases. The company has collaboration agreements with Amarin Corporation plc for the development and commercialization of ethyl icosapentate products; and Gene Techno Science Co., Ltd. to develop new regenerative medicine for the treatment of digestive rare and intractable diseases, such as congenital isolated hypoganglionosis. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.
URL
https://www.mochida.co.jp/
IPO date
May 13, 1963
Employees
1,529
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT